Cargando…
Exploring Synergy in Combinations of Tumor-Derived Vaccines That Harbor 4-1BBL, OX40L, and GM-CSF
Recent studies have demonstrated that combination of modulatory immune strategies may potentiate tumor cell elimination. Most strategies rely on the use of monoclonal antibodies that can block cell surface receptors to overcome tumor-induced immunosuppression or acting as costimulatory ligands to bo...
Autores principales: | Manrique-Rincón, Andrea J., Beraldo, Camila M., Toscaro, Jessica M., Bajgelman, Marcio C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610681/ https://www.ncbi.nlm.nih.gov/pubmed/28974950 http://dx.doi.org/10.3389/fimmu.2017.01150 |
Ejemplares similares
-
Extracellular vesicles produced by immunomodulatory cells harboring OX40 ligand and 4-1BB ligand enhance antitumor immunity
por: Semionatto, Isadora Ferraz, et al.
Publicado: (2020) -
Boosting antitumor response with PSMA-targeted immunomodulatory VLPs, harboring costimulatory TNFSF ligands and GM-CSF cytokine
por: Palameta, Soledad, et al.
Publicado: (2022) -
Boosting Antitumor Response by Costimulatory Strategies Driven to 4-1BB and OX40 T-cell Receptors
por: Mascarelli, Daniele E., et al.
Publicado: (2021) -
Recombinant GM-CSF for diseases of GM-CSF insufficiency: Correcting dysfunctional mononuclear phagocyte disorders
por: Lazarus, Hillard M., et al.
Publicado: (2023) -
GM-CSF-Dependent Inflammatory Pathways
por: Hamilton, John A.
Publicado: (2019)